TSE - NYSE

Good morning, ladies and gentlemen, and welcome to the Trinseo First Quarter 2022 Financial Results Conference Call. We welcome the Trinseo management team, Frank Bozich, President and CEO, David Stasse, Executive Vice President and CFO, and Andy Myers, Director of Investor Relations. Today’s conference call will include brief remarks by the management team, followed by a question-and-answer session. The company distributed its press release, along with its presentation slides, at close of market Wednesday, May 4th. These documents are posted on the company’s Investor Relations website and furnished on a Form 8-K filed with the Securities and Exchange Commission. [Operator Instructions] I will now hand the call over to Andy Myers.

Thank you, Sara, and good morning, everyone. At this time, all participants are in a listen-only mode. After our prepared remarks, instructions will follow to participate in the question-and-answer session. Our disclosure rules and cautionary note on forward-looking statements are noted on Slide two. During this presentation, we may make certain forward-looking statements, including issuing guidance and describing our future expectations. We must caution you that actual results could differ materially from what is discussed, described or implied in these statements. Factors that could cause actual results to differ include, but are not limited to, risk factors set forth in Item 1A of our Annual Report on Form 10-K or in our other filings made with the Securities and Exchange Commission. The company undertakes no obligation to update or revise its forward-looking statements. Today’s presentation includes certain non-GAAP measurements. A reconciliation of these measurements to corresponding GAAP measures is provided in our earnings release and in the appendix of our investor presentation. A replay of the conference call and transcript will be archived on the company’s Investor Relations website shortly following the conference call. The replay will be available until May 5, 2023. Now, I’d like to turn the call over to Frank Bozich.

Thanks Andy, and welcome to our first quarter earnings call. We had a very good start to the year with continued solid earnings in the first quarter. Q1 results reflect the continued progress we have made in reshaping our portfolio, as it was one of the highest quarterly adjusted earnings results in the company's history. I'm particularly pleased with this, as we're operating in a challenging macro environment, which now includes uncertainty and volatility from the conflict in Eastern Europe. Our thoughts are with the people of Ukraine, and I want to thank our employees who have shown great generosity through their donations to benefit those who've had their safety and wellbeing compromised. The conflict has had no direct impact on our operations, as all of our plants in the region or in Western Europe, with no regular direct suppliers in Ukraine, Russia or Belarus. However, we have observed indirect impacts in the region, including automotive production issues, as well as higher end more volatile prices of natural gas, and other inputs. We've taken proactive steps to mitigate some of these effects, including creating new mechanisms for customer pricing to more accurately pass through input costs. These actions have helped, but given the volatile environment, we're still subject to significant day-to-day swings in prices. I'm confident that our teams will continue to find ways to securely source raw materials and keep our operations running to provide customers with their quality products in a timely manner. While we contend with external challenges, our strategic focus continues to be on the transformation of Trinseo to a specialty material and sustainable solution provider. As you know, we've already taken several meaningful steps in this process, including the acquisitions of our PMMA business, Aristech Surfaces, and the recycled materials business, Healthland. These new businesses have greatly expanded the opportunity landscape organic growth, by providing us with access to new markets, new products, and new top line synergies due to our unique product portfolio. To realize these growth opportunities, we are focusing on three distinct dimensions of growth, which will impact our core business by strengthening the core, extending the core and expanding the core. Internally, we've begun to refer to these distinct efforts as our SEE strategy or S.E.E. for short [ph]. We'd like to elaborate on these three growth dimensions to provide some color on them and to highlight some of the progress we've made. First, our strengthen the core efforts focused on improving our position and the markets in which we currently operate, by reducing our cost position and our core chemistries, driving business excellence programs and delivering on cost synergies from our recent acquisitions. More importantly, our efforts to strengthen the core include our efforts to leverage our new capabilities to grow our total addressable market or TAM. A good example of growing our total addressable market is through material replacement, such as replacing painted metal exterior trim parts with color matched PMMA products. This application creates value for our customers by reducing emissions, weight and cost. Material replacement is a significant opportunity for us, because we can offer customers a quality product that not only costs less to use, but it's more environmentally friendly by virtue of eliminating process steps or alternative materials that have higher CO2 footprints. For example, because we have both PMMA and ABS in our portfolio, we're able to offer multiple end markets of PMMA laminate sheet in any color that's reinforced by ABS rather than the more conventionally used fiberglass. This cold laminate product which has Q1 sales volume growth of more than 20% versus prior year, provides customers with a solution that's both lower cost and more sustainable. In total, we believe we can expand our total addressable market in auto, building and construction and consumer goods by over $3 billion. The second area of growth focuses on those opportunities to extend the core, by moving the core business into new higher value added applications via M&A. We will also extend the core through the implementation of our sustainability roadmap, which has three building blocks. These efforts focused on decarbonizing our operations, developing an advantage product offering based on recycled materials, and lastly, developing a sustainable feedstock business. This involves positioning Trinseo as a leader in waste polymer collection and recycling and upgrading it to our innovative technologies, which will allow us to offer more sustainable solutions. That was the main rationale behind the recent acquisition of the plastics waste collector and recycler Heathland earlier this year. We've used security of supply of sustainable feedstocks as vital to our long term success and sustainability. While Heathland has been our first major step into recycling feedstocks, we will look to expand the sustainable business unit organically and inorganically. In addition to strengthening and extending our position in our core markets, we look to create additional opportunities to grow further by expanding the core through the addition of complementary technologies. This will be accomplished through targeted M&A of specialty businesses with attractive adjacent chemistries that broaden our offering into applications in mobility, building and construction, medical and consumer goods. The potential divestiture of the Styrenics business, which continues to progress, would provide us with capital that will aid in this effort. But setting aside the potential proceeds from the sale, we are well-positioned to grow. Thanks to our strong balance sheet, and a portfolio that is very cash generative with relatively low capital intensity. To effectively guide these S.E.E efforts, we have recently added three new executive leadership positions. Chief Sustainability Officer, Chief Commercial Officer, and Chief Technology Officer. These positions will report to me and be part of our executive leadership team. Francesca Reverberi was appointed as Chief Sustainability Officer last October. Our primary responsibility is to keep us on track to achieve our 2030 sustainability goals, as well as expand our product portfolio of sustainable materials, such as the recently launched MAGNUM BIO ABS Resin for automotive applications, which contains up to 80% bio attributed content. She will also take the lead in defining the investments and partnerships required to decarbonize our assets. In fact, her team's efforts have already defined an opportunity to decrease their already market leading Scope 1 and 2 emissions by over 70% by 2035, which is significantly ahead of our previously stated goal of 35% reduction. I am also thrilled to point out that our Q1 sales volume and variable margin of recycled containing solutions grew 39% and 31% respectively over the prior year. To give you a sense of scale for our sales of these solutions, they represent about $30 million in the annual variable margin. The role of Chief Commercial Officer was recently built by André Lanning, who was previously responsible for our Strategy and Corporate Development efforts. In his new role, André will ensure that we have the right commercial processes and tools in place to better serve our customers. He will also have oversight over all of our organic growth opportunities, and will provide the dedicated focus to resource and drive these market expanding efforts, which focus on material replacement. To give you some sense of scale for our existing material replacement activities, these represent about $100 million in annual variable margin. The role of Chief Technology Officer which we expect to fill soon will be responsible for creating a framework for our technology and innovation capabilities, that will allow us to provide solutions and products that differentiate Trinseo and expand our total addressable market. Before I turn the call over to Dave, I'd like to comments on our recent press release concerning the request for information related to styrene monomer purchasing activity that we received from the European Commission in 2018. As a result of further developments on this matter we've recorded a reserve of $36 million in the first quarter. We continue to cooperate fully and look forward to the resolution of this matter. Lastly, we do not expect this to impact the sales process of our Styrenics business. Now, I'd like to hand the call over to Dave, who will comments on our first quarter earnings.

Thank you, Frank. First quarter adjusted EBITDA of $178 million was similar to the prior year, but with an improvement in the quality of earnings as a specialty segments of our portfolio made up a larger share of our profitability. Last year's outsize contribution from feedstocks was replaced primarily by the incremental earnings from our acquired businesses and engineering materials. The benefits and the large favorable net timing variance in the first quarter of this year was mostly offset by about $20 million of headwinds, including lost sales from industry supply chain issues, and lower margin from volatile input costs. While we made progress in pricing to more effectively react to rapidly increasing input costs, a high level of volatility and the lag effect of pricing still led to some earnings headwinds mostly in engineering materials. The engineer materials segment also experienced a reduced benefit from ammonium sulfate sales during the quarter. Ammonium sulfate is a byproduct in the C3 MMA production process that we utilize in Europe. We produce about 180 kilo tonnes of ammonium sulfate per year and sell it into the fertilizer market in Europe. As most of you are probably already aware, nitrogen fertilizers in general have experienced a significant increase in price during the quarter because of the conflict in Ukraine. This historic price increased push demand out of the first quarter and into later quarters of 2022. We're already seeing demand return in Q2, as commodity grain prices are stimulating increased plantings in Europe. We have cash use of operations of $5 million during the first quarter, leading to a negative free cash flow of $30 million, which included a use of working capital of $103 million. We typically have a working capital use in the first quarter following seasonally lower December sales volume. But this year's draw was exacerbated by a steep rise in raw material prices and an inventory build ahead of planned turnarounds in the second quarter. We should generate higher cash in the coming quarters, as we don't expect a continuation of the rapid rise in raw materials, and as we run off inventories after mid year turnarounds. We'll continue to use the cash to grow the company and to return cash to shareholders, including via our share repurchase program, which as of the end of March still had $100 million of authorization remaining after another $50 million of repurchases during the first quarter. Now, I'll turn the call back over to Frank to comment on our updated guidance and expectations.

Thanks, Dave. Looking ahead to the second quarter, we expect earnings to be sequentially similar as higher styrene profitability, higher margins and engineered materials, and stronger volumes and latex binders are offset by more normalized margins and polystyrene ABS and polycarbonate products. We still expect 2022 to be another year of solid earnings, and we expect full year net income of $174 million to $211 million, and adjusted EBITDA of $625 million to $675 million. This outlook assumes that continuation of the Q1 demand levels through the end of the year, including impacts from the Ukraine conflict, inflationary pressure, and more modest automotive production growth. Our previous outlook reflected an easing of these conditions following the first quarter, it did not consider a military conflict in Europe or ongoing COVID lockdowns in China. This also includes an anticipated $35 million impact in the second quarter from the current styrene production outages at our Terneuzen site and AmSty’s St. James site. In addition, we expect no meaningful net timing impact over the remainder of the year. We expect to generate cash from operations of approximately $355 million and free cash flow of approximately $175 million, which we'll use to continue to provide value to shareholders by both growing the business in specialty and sustainable areas and providing cash returns. Certainly, there's no shortage of uncertainty in the world right now. But we're well positioned to navigate this environment with our strong balance sheet, continued progress on our transformation journey and skilled teams to provide our customers with the quality products and solutions. Now we're happy to take questions. Thank you.

[Operator Instructions] Our first question comes from the line of Frank Mitsch with Fermium Research. Your line is open.

Good morning, and thank you for the additional color. I was wondering in your comments as well as in release, you're saying that the styrenics divestiture process that you're running continues to progress. So, I was wondering if you might be able to provide any more color on perhaps the timing or the interest level that you're seeing there? There has been some concerns that with the energy situation in Europe that might have made things a bit more problematic. Any color that would be very helpful?

Yes, Frank. As we've said previously, we expect to see this -- our process play out by mid year and it continues to progress as we expect it. So, we haven't seen any negative impacts in our process related to the energy price increases in Europe.

Fantastic. Very helpful. And we saw this timing margins come in better than anticipated and I was wondering, what's your outlook is there?

We think styrene margin with -- well, the styrene margins are significantly elevated right now, because of a number of outages in the industry as well as the arbitrage window being unavailable because of logistics challenges. So, we see that fly up margin or the higher than normal margins in styrene should continue through Q2, but then normalize in the second half of the year to basically a zero EBITDA contribution level. In Europe, but [Indiscernible] will revert back to its normalized earnings levels, because of their advantage cost positions.

Very helpful. Thanks so much.

Your next question comes from the line of David Begleiter with Deutsche Bank. Your line is open.

Good morning, Frank and Dave. Guys, can you just bridge the EBITDA reduction guidance. I know, a big chunk of that is the -- are the outage at Terneuzen and St. James. Can you bridge the remainder of that? I think $75 million decrease the midpoint of the current and prior EBITDA guidance?

So, maybe I'll give you. I think the simple answer is we think that -- we think the rest of the year will continue at an environment similar to what we experienced in Q1 with the elimination of the timing benefit and the fly off margin that we're currently seeing in styrene margins ending and not recurring in the second half of the year. So, that's how we get to the full year. To the extent that there's an improvement in the conditions that we see versus Q1, there would be some upset.

As Dave alluded to that answer, if you don't mind, the -- to be clear on the $75 million reduction, you correctly highlighted the $35 million that we expect the impact of the outages to be in the quarter, and that's across both America Styrenics and our own feedstock segment. That is not a component of the $75 million. Because our prior guidance didn't assume those fly off margins to begin with. Right? So that's -- so I think, to -- so the real composition, the change in guidance is entirely due to a change in our assumptions on the business conditions through the rest of the year, from what we gave in the first quarter. And to break that down a little more. Finally, I mean, there's really three components that there's automotive demand, which is the cross base plastics, managing materials, there's lower margin than polycarbonate that we highlighted. And the other bucket is -- a really a lot of smaller things, but are really attributable to the same thing that we've been talking about supply chain challenges. And, COVID related shutdown issues in China. Those are largely the three buckets. But I just want to make sure you understand that the $35 million is not part of that bridge.

No. Very helpful, Dave. Thank you for that. And just on ammonium sulfate, can you quantify the shift of earnings from Q1 to the back half of the year? And what's normalized earnings in that line of business you guys?

Well, the way we account for that, Dave, it is a byproduct of producing an MMA. So the way we account for it, we don't book revenue and margin that you would see it. It's booked as a credit to the manufacturing costs. Okay. So, it lowers cost a good sold I guess he would say. I probably wouldn't consider that Dave to be a prophet. I mean, it obviously is profitable. But the way we think about it is it's a natural hedge against -- it's a natural hedge that exists in that business against a portion of our natural gas purchases. And the reason I say that is, what drives the price of ammonium sulfate is the price of ammonia. What drives the price of ammonia, its natural gas. So the sales of that byproduct -- the sales, the dollar amount of those sales is really driven by the price of natural gas. And like I said, the income, if you will, that we recognize from the sales really serve as a natural offset of part of our natural gas purchases. Does that make sense?

It does. And appreciate that detail. Thank you.

Your next question comes from the line of Hassan Ahmed with Alembic Global Advisors. Your line is open.

Morning, Frank and Dave. A question around EM segment margins. They jumped out nicely sequentially from, call it 9.4% to 11.9%. The question is that, I mean, obviously, 2022 is certainly not a normal year with all the crosscurrents we're seeing be it logistical, be it sort of auto and market demand and the like. Two fold question. One is, where would these margins sit through the course of 2022? And where do you see them going in a more normalized environment?

So, thanks for the question. And what -- let me first point out that is, as Dave mentioned, we did have some headwinds in Q1 that we highlighted in the earnings release. In fact, we said, approximately $20 million of non recurring headwinds in the first quarter I would say slightly less than half of that accrued to EM. So, you could expect that in Q1, we would have had low $40 million adjusted EBITDA contribution from EM minus those non-recurring items, that puts us into the mid teen range. Now, what historically or when we guided to or gave some feedback on where we envision EM being in the low $20 million are, over $50 million quarterly EBITDA contribution, that contemplates a normalization of auto builds to a level that we were anticipating. Historically, but it also contemplate that the supply chain issues and the extreme freight inflation coming out of China, normalizes, because those two factors are depressing, let's say, demand for EM materials. So I think in the near term, we expect that those one time issues to go away. And in the medium term, as we continue growing these growth programs, as well as we see markets in China and in automotive normalizing, we would get into the low 50s.

Very helpful, Frank. And as a follow up, in the press release, you guys put out, there was a line stating that the synergy pipeline is greater than anticipated. I'd love some sort of further color around that?

So the on the cost synergies, we're clearly on track to deliver the year one savings of $10 million, we're clearly above that. The full synergies between the Aristech Surfaces, as well as the PMMA acquisition were in total cost savings synergies were $60 million, is what we stated over the three-year period, the first three years, we're well on track to achieve those and we see greater -- a bigger pipeline than that $60 million in aggregate, where it's significantly higher is on the growth side. And as I mentioned, in the market expansion opportunities that we have that we previously didn't have, we can expand our total addressable market by over $3 billion. And so, it's a very significant expansion opportunity. And as I said in the script, it was -- those market, material replacement activities today that are ongoing, represent $100 million in annual variable margin. So they're ongoing. They're significant already and they're growing much faster than the market, because of the value proposition that we offer. So that's the color I would give you.

Very helpful, Frank. Thank you so much.

Sure.

Your next question comes from the line of Lawrence Alexander with Jeffries. Your line is open.

Good morning. A question about sort of your customer activity. I mean, to what extent in the range of end-market to exposure to, to what extent are any customer or value chains, not living hand-to-mouth, that is selling everything they produce? Are you seeing any signs of customers need to get some slack and build inventory?

I would say, generally the answer is no. We aren't really seeing inventories being built in any of the major markets that we participate in.

And can you give a feel for kind of the level of incentives and kind of capital intensity of expanding capacity in your downstream businesses, given how strong demand is and the size of the opportunity in the new product replacement areas?

Yes. So in the in the product replacement technologies, there -- it's a mixed bag. And I would say there's probably five distinct opportunities that we have. Many of these we have the ability to grow organically with very little capital investments. So single digit to low double digit million capital investments to effect the growth in those areas. So, they are not capital intensive and we have the ability to grow them significantly.

Okay. Thank you.

One. I guess the one thing is that we've pointed this out previously, we will make an expansion of our PMMA business into Asia. And that capital is in the mid double digit million capital size. Now, I do want to spend a second on the opportunities that I highlighted to reduce the carbon footprint of our business, because we see, not only does it improve our environmental footprint, but it creates an OpEx savings and reduces our energy dependence. And they're the $70 million in or 70% reduction in Scope 1 and 2 emissions that I referenced in the script is associated with approximately $100 million of capital investment over the rest of this decade.

Okay. Perfect. No, that's helpful. Thanks.

[Operator Instructions] Our next question comes from the line of Angel Castillo with Morgan Stanley. Your line is open.

Hi. Thanks for taking my question. Just a quick one on the normalization around margins for ABS, polystyrene and polycarbonate. One, I wonder if you could give us a little bit more color as to what you're seeing across it? I know, that [Indiscernible] market within maybe ABS/PC. But across other end-market what are seeing? And specifically as we think about second half and the margin normalization of these products, where do they go in second half? And where do they kind of as we think about 2023 and in a more kind steady state environment?

Well, let me -- I'll give some background. So, as you know PC and ABS, the biggest consuming regions of in the world is China. With some of the rolling lockdowns, the demand in Asia has been reduced. And at the same time we've seen low double-digit capacity expansions to the global supply occur in PC and ABS in Asia. And so, that's put some margin pressure or make these, the supply/demand balance, its gotten a big long. And we anticipate that staying through the remainder of the year, and that's what's driving the normalization of the margins that we anticipate.

Got it. That's very helpful. And I guess as you think about, I think the guidance right now implies something like a $150 million type EBITDA in the back half kind of exit rate. So roughly $600 million on an annualized basis. Is that the level you would kind of anticipate as we move forward? Or it sounds like it's fairly U.S. or its autos and other end markets recover you would anticipate further, I guess, improvement in that. But just as we think about other products normalizing like ABS/PC, would you anticipate some kind of offset? And therefore $600 million is roughly kind of a good level as we think beyond 2022? Or is that -- how would you think about it?

Yes. Angel, the answer is yes. This is Dave. The answer is yes. There is an offset. And the offset is going to be improvement in engineered materials for the reasons that we just talked about. So, to be clear, and just to add on to what Frank said, I mean, I think that the direct question was, is there still some over name that exists in base plastics and polystyrene in Q1? I mean, clearly, we highlighted the Q4 was -- there was some over earning. And that over earnings -- there probably was some over earning that existed in the first quarter also. So you're right. We do expect the normal -- kind of a normalization of margins in both polystyrene and base plastics as we go to the back half of the year. To put a number on that on a quarterly basis, I would say, the two of those combined, probably over earned by $20 million to $25 million in the first quarter. So that's what -- that's the magnitude, I'd say, of the normalization. So, and you're right also, what the guidance implies is, order of magnitude $150 million, or $600 a quarter in the back half of the year. Moving, what will offset that decline? I mean, there's clearly improvement in engineered materials. And the other thing is, realization of synergies. As Frank said, I'm talking about the cost synergies here. As Frank said, we're well ahead of our what we said, was the target for the first quarter and looking at for the first year, and looking ahead to the second year. So I think those two things combined are what offsets the decline, Angel.

Very helpful. Thank you.

Your next question comes from the line of Matthew Blair from Tudor, Pickering, Holt & Company. Your line is open.

Yes. Good morning, everyone. So I think back in December you announced the $200 million buyback program over the next 18 months. Q1 buybacks quite strong over $50 million. How should we think about the cadence of buybacks in Q2 and beyond? And is there potential for you to re-up this program, finish it early and re-up it at higher levels?

Yes. Hi, Matthew. It's Dave again. Yes. Look, is there a potential? I mean, absolutely. As I said, we have another $100 million left under the authorization. We see a lot of value in buying back our stock at these levels. I would expect Q2 to be a similar number to Q1. And as when the program exhausts ourselves, we'll talk to our board in light of our balance sheet position, and whatever are -- what other cash needs we have and have a discussion about putting in place a new authorization. But -- so I don't want to -- I can't really comment beyond that other than to say that we clearly see a lot of value in buying back stock at our current multiple and cash flow yield and Q2 expect a similar number to Q1 and Q4.

I'll leave it there. Thank you.